CXCL12 and plasma cell myeloma: In MCL, as well as other hematological malignancies, such as chronic lymphocytic leukemia and myeloma, CXCR4/CXCL12 is known to mediate tumor cell migration (“homing”) and adhesion to bone marrow stromal cells, which function as a protective microenvironment 6-9.